PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Laboratory Medicine, Chungnam National University School of Medicine, Daejeon, Republic of Korea; Department of Laboratory Medicine, Chungnam National University Sejong Hospital, Sejong, Republic of Korea.\', \'Department of Laboratory Medicine, Chungnam National University Sejong Hospital, Sejong, Republic of Korea.\', \'Division of Infectious Diseases, Department of Internal Medicine, Chungnam National University School of Medicine, Chungnam National University Sejong Hospital, Sejong, Republic of Korea.\', \'Department of Laboratory Medicine, Chungnam National University School of Medicine, Daejeon, Republic of Korea; Department of Laboratory Medicine, Chungnam National University Sejong Hospital, Sejong, Republic of Korea. Electronic address: qutechoi@gmail.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0264-410X(21)01620-010.1016/j.vaccine.2021.12.012
?:doi
?:hasPublicationType
?:journal
  • Vaccine
is ?:pmid of
?:pmid
?:pmid
  • 34953606
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.863
?:rankingScore_hIndex
  • 159
?:title
  • Antibody response to second dose of the BNT162b2 mRNA vaccine in the first 12 weeks in South Korea: A prospective longitudinal study.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all